A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
Public ClinicalTrials.gov record NCT00659100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 3-Month, Open-Label, Pharmacy-Based, Actual-Use Trial in a Simulated Over-The-Counter (OTC) Environment to Assess Self-Selection and Consumer Use Patterns of Gabapentin 250 mg for Occasional Sleeplessness
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess consumers' behaviors related to gabapentin self- selection and use, relative to warnings and directions for use, as described in the proposed over-the-counter (OTC) product label.
Study identification
- NCT ID
- NCT00659100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,254 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2006
- Primary completion
- Not listed
- Completion
- Dec 31, 2006
- Last update posted
- Feb 1, 2021
2006 – 2007
United States locations
- U.S. sites
- 35
- U.S. states
- 11
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Anaheim | California | 92801 | — |
| Pfizer Investigational Site | Bonita | California | 91902 | — |
| Pfizer Investigational Site | Fallbrook | California | 92028 | — |
| Pfizer Investigational Site | Hacienda Heights | California | 91746 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Oceanside | California | 92054 | — |
| Pfizer Investigational Site | Orange | California | 92866 | — |
| Pfizer Investigational Site | San Dimas | California | 91773 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33026 | — |
| Pfizer Investigational Site | Weston | Florida | 33326 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21228 | — |
| Pfizer Investigational Site | Elk River | Minnesota | 55330 | — |
| Pfizer Investigational Site | Northfield | Minnesota | 55057 | — |
| Pfizer Investigational Site | Red Wing | Minnesota | 55066 | — |
| Pfizer Investigational Site | Saint Louis Park | Minnesota | 55426 | — |
| Pfizer Investigational Site | Holly Springs | Mississippi | 38625 | — |
| Pfizer Investigational Site | Belton | Missouri | 64012 | — |
| Pfizer Investigational Site | Independence | Missouri | 64054 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87104 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87110 | — |
| Pfizer Investigational Site | Taos | New Mexico | 87571 | — |
| Pfizer Investigational Site | Cary | North Carolina | 27513 | — |
| Pfizer Investigational Site | Chapel Hill | North Carolina | 27514 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27606 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27612 | — |
| Pfizer Investigational Site | Houston | Texas | 77088 | — |
| Pfizer Investigational Site | Pearland | Texas | 77581 | — |
| Pfizer Investigational Site | Bountiful | Utah | 84010 | — |
| Pfizer Investigational Site | Ogden | Utah | 84401 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84121 | — |
| Pfizer Investigational Site | Syracuse | Utah | 84075 | — |
| Pfizer Investigational Site | West Valley City | Utah | 84120 | — |
| Pfizer Investigational Site | Falls Church | Virginia | 22041 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Transient Insomnia trials
Other public records listing Transient Insomnia. Sorted by last update posted; newest first. Not a recommendation.
- NCT04396327: SM-1 vs. an Active Comparator in A Model of Transient Insomnia Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00659100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2021 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00659100 live on ClinicalTrials.gov.